Company Email Format

Immix Biopharma (Nasdaq: IMMX)

Biotechnology Los Angeles, California, United States 25 employees IMMX

Employees: 25
Contacts: 4
Emails: 4
Phones: 2

immixbio.com LinkedIn Crunchbase

Immix Biopharma (Nasdaq: IMMX) Overview

Headquarters: Los Angeles, California, United States
Phone Number: Available in AeroLeads
Website: immixbio.com
Industry: Biotechnology
Employees: 25
Founded: 2012
Stock Symbol: IMMX
Funding: 15.0M
Company Email: Available in AeroLeads

About Immix Biopharma (Nasdaq: IMMX)

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and other autoimmune diseases. Our lead cell therapy is FDA IND cleared next generation CAR-T NXC-201, currently being evaluated in our ongoing Phase 1b/2 NEXICART-1 (NCT04720313) clinical trial, initiated in February 2021. NXC-201 has the potential to be the world’s first “Single-Day CRS” CAR-T (CRS median onset day 1, median duration 1 day), enabling the potential for a faster return home for patients and supporting ongoing expansion into autoimmune indications. NXC-201 has been awarded Orphan Drug Designation (ODD) by the FDA in both AL Amyloidosis and multiple myeloma, and ODD by the European Commission (EMA) in AL Amyloidosis. Learn more at www.immixbio.com and www.BeProactiveInAL.com.

Immix Biopharma (Nasdaq: IMMX) Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Immix Biopharma (Nasdaq: IMMX) Org Chart

Sample employees and titles

Name	Title	Location	Contact
Alvin Viray	Associate Director at Uci Applied	Irvine, California, United States	Email
Matthew Deangelis		Belmar, New Jersey, United States	Email Phone
Jason Hsu	Founder & CIO at Rayliant Global	Boston, Massachusetts, United States	Email Phone
Helen C. Hutchison Adams	Lead Independent Director and Audit	San Diego, California, United States	Email